Cryolife Inc (NYSE:CRY) Move as Institutional Investors’ Sentiment Up

April 17, 2018 - By Nellie Frank

CryoLife, Inc. (NYSE:CRY) Logo

Sentiment for Cryolife Inc (NYSE:CRY)

Cryolife Inc (NYSE:CRY) institutional sentiment decreased to 1.33 in Q4 2017. Its down -0.26, from 1.59 in 2017Q3. The ratio fall, as 57 investment professionals started new and increased equity positions, while 43 cut down and sold equity positions in Cryolife Inc. The investment professionals in our partner’s database now hold: 24.23 million shares, up from 23.69 million shares in 2017Q3. Also, the number of investment professionals holding Cryolife Inc in their top 10 equity positions was flat from 0 to 0 for the same number . Sold All: 14 Reduced: 29 Increased: 44 New Position: 13.

CryoLife, Inc., together with its subsidiaries, makes and distributes medical devices worldwide. The company has market cap of $851.67 million. It also processes and distributes implantable human tissues for use in cardiac and vascular surgeries. It has a 217.29 P/E ratio. The firm operates in two divisions, Medical Devices and Preservation Services.

The stock increased 4.49% or $1 during the last trading session, reaching $23.25. About 89,900 shares traded. CryoLife, Inc. (NYSE:CRY) has risen 19.34% since April 17, 2017 and is uptrending. It has outperformed by 7.79% the S&P500.

Analysts await CryoLife, Inc. (NYSE:CRY) to report earnings on April, 25. They expect $-0.04 earnings per share, down 144.44 % or $0.13 from last year’s $0.09 per share. After $0.11 actual earnings per share reported by CryoLife, Inc. for the previous quarter, Wall Street now forecasts -136.36 % negative EPS growth.

Thomson Horstmann & Bryant Inc holds 0.86% of its portfolio in CryoLife, Inc. for 339,410 shares. Elk Creek Partners Llc owns 645,333 shares or 0.73% of their US portfolio. Moreover, Nbw Capital Llc has 0.42% invested in the company for 84,173 shares. The Pennsylvania-based Connors Investor Services Inc has invested 0.29% in the stock. Next Century Growth Investors Llc, a Minnesota-based fund reported 74,850 shares.#img1#

Since January 1, 0001, it had 0 insider buys, and 3 insider sales for $169,448 activity.

CryoLife, Inc. (NYSE:CRY) Ratings Coverage

Ratings analysis reveals 100% of Cryolife’s analysts are positive. Out of 2 Wall Street analysts rating Cryolife, 2 give it “Buy”, 0 “Sell” rating, while 0 recommend “Hold”. The lowest target is $23.5 while the high is $28.0. The stock’s average target of $25.75 is 10.75% above today’s ($23.25) share price. CRY was included in 4 notes of analysts from October 31, 2017. Canaccord Genuity maintained the shares of CRY in report on Tuesday, October 31 with “Buy” rating. The rating was maintained by Canaccord Genuity with “Buy” on Thursday, March 8. The company was maintained on Monday, November 13 by Northland Capital. The firm has “Buy” rating given on Tuesday, January 2 by Canaccord Genuity.

CryoLife, Inc. (NYSE:CRY) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: